BIOMAT Database Logo BIOMAT Database Logo

Therapeutic ranges for oral anticoagulation in different thromboembolic disorders. 1992

L Poller
UK Reference Laboratory for Anticoagulant Reagents and Control, Withington Hospital, Manchester.

UI MeSH Term Description Entries
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

L Poller
Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation.
January 1985, Acta haematologica,
L Poller
[Oral anticoagulation: the therapeutic range with different thromboplastins].
March 1977, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
L Poller
Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation.
April 2024, Trends in cardiovascular medicine,
L Poller
Thromboembolic disorders and oral contraceptives.
February 1969, JAMA,
L Poller
Thromboembolic disorders and oral contraceptives.
May 1969, JAMA,
L Poller
[Therapeutic ranges of oral anticoagulant therapy in different diseases. Guidelines of the Federation of Centers of Surveillance of Patients on Anticoagulation. Ad hoc Study Group].
January 1996, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
L Poller
Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
June 2005, The American journal of medicine,
L Poller
[The therapeutic scope of oral anticoagulation].
October 1977, Schweizerische medizinische Wochenschrift,
L Poller
[Control of oral anticoagulation--therapeutic range].
September 1977, Schweizerische medizinische Wochenschrift,
L Poller
Thromboembolic disorders and oral contraceptives (author's response).
February 1969, JAMA,
Copied contents to your clipboard!